Results 71 to 80 of about 14,172 (249)

Safety and effectiveness of fingolimod in Japanese patients with multiple sclerosis: Results of a post‐marketing surveillance study

open access: yesClinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 118-131, May 2025.
Abstract Objective Fingolimod is the first oral sphingosine‐1‐phosphate receptor modulator approved in Japan for multiple sclerosis (MS). A large Japanese observational study of fingolimod in patients with MS was carried out to support its safety and effectiveness in a real‐world setting.
Noriko Sato   +7 more
wiley   +1 more source

Clinical observation on radiant shock wave in the treatment of postherpetic neuralgia

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2013
Objective To evaluate the effect of radiant shock wave therapy (RSWT) on postherpetic neuralgia. Methods Twenty-six cases of postherpetic neuralgia were treated with RSWT around the pain point.
Xiao-hua LIU   +3 more
doaj  

Impaired Modulation of Pain in Patients with Postherpetic Neuralgia

open access: yesPain Research and Management, 2014
BACKGROUND: The efficiency of inhibitory pain descending pathways (evaluated using conditioned pain modulation [CPM]) has not been studied in postherpetic neuralgia (PHN).
Gisèle Pickering   +4 more
doaj   +1 more source

The management of postherpetic neuralgia [PDF]

open access: yesPostgraduate Medical Journal, 1997
Summary Postherpetic neuralgia is defined as pain persisting, or recurring, at the site of shingles at least three months after the onset of the acute rash. Thus defined, at least half of shingles sufferers over the age of 65 years develop postherpetic neuralgia. In addition to increasing age, less important risk factors for postherpetic
openaire   +3 more sources

Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study [PDF]

open access: yes, 2017
Background In randomised studies, the capsaicin 8% patch has demonstrated effective pain relief in patients with peripheral neuropathic pain (PNP) arising from different aetiologies.
Berni, Ellen   +10 more
core   +3 more sources

Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults

open access: yesTherapeutics and Clinical Risk Management, 2013
Ben M Thomas,1 Paul Farquhar-Smith2 1Chelsea Westminster Hospital, London, UK; 2Department of Anaesthetics, The Royal Marsden NHS Foundation Trust, London, UK Abstract: The development of biomedical technology is allowing refinement of drug therapies in ...
Thomas BM, Farquhar-Smith P
doaj  

Animal models of human herpesvirus infection

open access: yesAnimal Models and Experimental Medicine, Volume 8, Issue 4, Page 615-628, April 2025.
Human herpesvirus can infect humans and other vertebrates, primarily targeting the skin, mucous membranes, and neural tissues, thereby significantly impacting the health of both humans and animals. Animal models are crucial for studying virus pathogenesis, vaccine development, and drug testing.
Ziqing Jia   +3 more
wiley   +1 more source

Neuralgias of the Trigeminal Nerve

open access: yesPain Research and Management, 2000
Practitioners are often presented with patients who complain bitterly of facial pain. The trigeminal nerve is involved in four conditions that are sometimes mixed up.
Allan S Gordon
doaj   +1 more source

Application of 35 kDa Hyaluronic Acid Fragment in Managing Persistent Localized Pain in Rheumatoid Arthritis : A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic joint inflammation, leading to joint damage and pain. This case report presents a 58‐year‐old Chinese female who developed widespread joint pain after contracting mild COVID‐19 and was subsequently diagnosed with RA.
Li Liu   +4 more
wiley   +1 more source

Extraction and Optimization of Lycopene From Selected Fruits and Their Assessment as an Ultraviolet Ray Protectant for Escherichia coli

open access: yesFood Science &Nutrition, Volume 13, Issue 4, April 2025.
Solanum lycopersicum had the highest (3.36024 μg/mL), whereas Capsicum annuum (0.31824 μg/mL) had the lowest lycopene concentration. S. lycopersicum lycopene showed the highest UV‐ray blocking efficiency, inhibiting 99.75% of UV rays after 72 hours. Lycopene shows significant potential as a UV protectant in bacterial cultures, suggesting it could be ...
Anil Kumar   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy